Sleep Disorders Trial, Recruiting NCT06386497 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06386497
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed an informed consent form agreeing to take part in the study
  • People who have been diagnosed with Parkinson's disease according to recognised medical diagnostic guidelines
  • People who have poor sleep quality, as shown by a score of more than 5 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index (PSQI)
  • People whose medications for Parkinson's disease, depression, and sleep have been at a stable dose for at least six weeks before the study starts, and who are able to keep those doses stable throughout the study
  • People who have not had a treatment called bilateral deep brain stimulation (a surgical procedure involving both sides of the brain)
  • People who are fluent in German

Who may not be able to join:

  • People who have a brain condition other than Parkinson's disease, such as atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, or similar conditions
  • People who have dementia, as identified by a score lower than 24 out of 30 on a standard cognitive assessment called the MoCA
  • People who weigh more than 150 kg
  • People who are currently experiencing depression with active thoughts of suicide
  • People who have a major ongoing psychiatric condition that is not currently under control, such as active psychosis
  • People who have serious ongoing health problems that are not well managed, such as uncontrolled diabetes, uncontrolled high blood pressure, or current treatment for cancer
  • People who would be unable to follow the study procedures — for example, completing questionnaires — due to language barriers, psychological difficulties, or dementia
  • People who have taken part in another interventional clinical trial within the 30 days before this study starts, or who are currently in another interventional trial
  • People who score 5 or below on the Pittsburgh Sleep Quality Index (PSQI), indicating sleep quality that does not meet the study's threshold

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lenard Lachenmayer, MD, Insel Gruppe AG, University Hospital Bern

Phone: 31 66 4 12 59

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Insel Gruppe AG, University Hospital Bern
Registry
ClinicalTrials.gov
Start date
11 January 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Evaluation of acceptability and feasibility; Evaluation of acceptability and feasibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov